Literature DB >> 15610715

Management of common symptoms of advanced lung cancer.

Michelle Bedor1, Carla Alexander, Martin J Edelman.   

Abstract

Disease-directed treatment of lung cancer reduces the morbidity and extends life for patients. However, as providers we must recognize that treating the symptoms of the disease may be as important as the treatment of the disease itself. This is particularly true in advanced disease and after disease-directed therapies have been exhausted. Aggressive assessment of symptoms and use of palliative therapies can significantly reduce the symptomatology of advanced lung cancer. Though the impact of these symptoms (ie, pain, dyspnea, and cachexia) are well known, they tend to be under-treated. In addition, simple maneuvers such as opiate rotation for pain relief are underutilized. The diagnosis of lung cancer and its associated symptoms may result in severe psychosocial stress for the patient and further exacerbate the symptoms in a vicious cycle. Understanding of coping strategies may aid the medical provider in assisting the patient during his or her illness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15610715     DOI: 10.1007/s11864-005-0013-2

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  23 in total

Review 1.  Pharmacologic management of cancer pain.

Authors:  M H Levy
Journal:  Semin Oncol       Date:  1994-12       Impact factor: 4.929

2.  Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer.

Authors:  E L Smith; D M Hann; T A Ahles; C T Furstenberg; T A Mitchell; L Meyer; L H Maurer; J Rigas; S Hammond
Journal:  J Pain Symptom Manage       Date:  2001-04       Impact factor: 3.612

3.  Factors influencing physician management of cancer pain.

Authors:  C S Cleeland; L M Cleeland; R Dar; L C Rinehardt
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

4.  Nutritional intake, weight change, symptom distress, and functional status over time in adults with lung cancer.

Authors:  L Sarna; A M Lindsey; H Dean; M L Brecht; R McCorkle
Journal:  Oncol Nurs Forum       Date:  1993-04       Impact factor: 2.172

Review 5.  Management of dyspnea in advanced cancer patients.

Authors:  C Ripamonti
Journal:  Support Care Cancer       Date:  1999-07       Impact factor: 3.603

Review 6.  Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea.

Authors:  D D Ross; C S Alexander
Journal:  Am Fam Physician       Date:  2001-09-15       Impact factor: 3.292

7.  Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain.

Authors:  Natalie Moryl; Juan Santiago-Palma; Craig Kornick; Susan Derby; Daniel Fischberg; Richard Payne; Paolo L Manfredi
Journal:  Pain       Date:  2002-04       Impact factor: 6.961

8.  Intractable pain with lung cancer.

Authors:  Peter N Watson; Ramon J Evans
Journal:  Pain       Date:  1987-05       Impact factor: 6.961

Review 9.  Nutritional support in patients with advanced cancer: permission to fall out?

Authors:  A W McKinlay
Journal:  Proc Nutr Soc       Date:  2004-08       Impact factor: 6.297

Review 10.  Management of paraneoplastic syndromes in lung cancer.

Authors:  Leno Thomas; Young Kwok; Martin J Edelman
Journal:  Curr Treat Options Oncol       Date:  2004-02
View more
  1 in total

1.  Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies.

Authors:  Andrew M Scott; Paul L Mitchell; Graeme O'Keefe; Timothy Saunder; Rodney J Hicks; Aurora Poon; Charles Baum; Nicoletta Brega; Timothy J McCarthy; Guy C Toner
Journal:  EJNMMI Res       Date:  2012-06-09       Impact factor: 3.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.